Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B U Sevin

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
Gynecologic Oncology|October 1, 1995
Combination anti-gene therapy targeting c-myc and p53 in ovarian cancer cell linesM F Janicek, B U Sevin, H N Nguyen, et al.
Cancer|October 15, 1987
Surgical staging of gynecologic malignanciesH E Averette, D M Donato, J L Lovecchio, et al.
American Journal of Hematology|February 1, 1996
Danazol relieves refractory pruritus associated with myeloproliferative disorders and other diseasesL Kolodny, L L Horstman, B U Sevin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Extranodal Rosai-Dorfman disease as a pelvic massB J L Leiva, R M Bofill, B-U Sevin, et al.
Obstetrics and Gynecology|October 1, 1984
Antibiotic prevention of infections complicating radical abdominal hysterectomyB U Sevin, R Ramos, M Lichtinger, et al.
Cancer|April 15, 1996
Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervixB U Sevin, M W Method, M Nadji, et al.
Archives of Gynecology and Obstetrics|January 1, 1991
Long-term survival in stage III and IV ovarian cancerE Petru, B U Sevin, H E Averette, et al.
Cancer|October 15, 1992
Microinvasive carcinoma of the cervixB U Sevin, M Nadji, H E Averette, et al.
Cancer|February 15, 1993
Chemosensitivity testing in ovarian cancerB U Sevin, J P Perras, H E Averette, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Spectrum of cell-cycle kinetics of alkylating agent adolezesin in gynecological cancer cell lines: correlation with drug-induced cytotoxicityH N Nguyen, B U Sevin, H Averette, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Gynecologic Oncology|October 1, 1995
Combination anti-gene therapy targeting c-myc and p53 in ovarian cancer cell linesM F Janicek, B U Sevin, H N Nguyen, et al.
Cancer|October 15, 1987
Surgical staging of gynecologic malignanciesH E Averette, D M Donato, J L Lovecchio, et al.
American Journal of Hematology|February 1, 1996
Danazol relieves refractory pruritus associated with myeloproliferative disorders and other diseasesL Kolodny, L L Horstman, B U Sevin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 7, 2006
Extranodal Rosai-Dorfman disease as a pelvic massB J L Leiva, R M Bofill, B-U Sevin, et al.
Obstetrics and Gynecology|October 1, 1984
Antibiotic prevention of infections complicating radical abdominal hysterectomyB U Sevin, R Ramos, M Lichtinger, et al.
Cancer|April 15, 1996
Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervixB U Sevin, M W Method, M Nadji, et al.
Archives of Gynecology and Obstetrics|January 1, 1991
Long-term survival in stage III and IV ovarian cancerE Petru, B U Sevin, H E Averette, et al.
Cancer|October 15, 1992
Microinvasive carcinoma of the cervixB U Sevin, M Nadji, H E Averette, et al.
Cancer|February 15, 1993
Chemosensitivity testing in ovarian cancerB U Sevin, J P Perras, H E Averette, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Spectrum of cell-cycle kinetics of alkylating agent adolezesin in gynecological cancer cell lines: correlation with drug-induced cytotoxicityH N Nguyen, B U Sevin, H Averette, et al.
Pageof 14